Clinical Trials

Search for actively enrolling clinical trials

Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents 6 to 18 years of age

Study ID: STU-2021-0107

Summary

nada!

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
DERYK LEE WALSH

Contact:

Christina Howard

CHRISTINA.HOWARD@UTSouthwestern.edu

Linked In Email
scroll to top